Showing results (1321-1330 of 1,340) with videos related to

Sort By:
Pageof 134
ACS Chemical Biology|February 28, 2018
Functionally Biased D2R Antagonists: Targeting the β-Arrestin Pathway to Improve Antipsychotic TreatmentMichel Weïwer, Qihong Xu, Jennifer P Gale, et al.
Trends in Neurosciences|April 26, 2018
Progress in Understanding and Treating SCN2A-Mediated DisordersStephan J Sanders, Arthur J Campbell, Jeffrey R Cottrell, et al.
Science Translational Medicine|March 9, 2018
Exploiting an Asp-Glu "switch" in glycogen synthase kinase 3 to design paralog-selective inhibitors for use in acute myeloid leukemiaFlorence F Wagner, Lina Benajiba, Arthur J Campbell, et al.
Orphanet Journal of Rare Diseases|February 15, 2022
Dual guidance structure for evaluation of patients with unclear diagnosis in centers for rare diseases (ZSE-DUO): study protocol for a controlled multi-center cohort studyHelge Hebestreit, Cornelia Zeidler, Christopher Schippers, et al.
The Journal of Biological Chemistry|July 30, 2020
Multimodal small-molecule screening for human prion protein bindersAndrew G Reidenbach, Michael F Mesleh, Dominick Casalena, et al.
Nature Communications|June 2, 2017
Experimental discrimination of ion stopping models near the Bragg peak in highly ionized matterW Cayzac, A Frank, A Ortner, et al.
Cell Systems|September 3, 2022
Virtual screening for small-molecule pathway regulators by image-profile matchingMohammad H Rohban, Ashley M Fuller, Ceryl Tan, et al.
Vox Sanguinis|December 1, 2025
International Society of Blood Transfusion Working Party on Red Cell Immunogenetics and Blood Group Terminology Report of Gothenburg, Barcelona and four virtual business meetings: Update on blood group systemsCatherine A Hyland, Lilian Castilho, Qing Chen, et al.
ACS Chemical Biology|April 30, 2016
Inhibitors of Glycogen Synthase Kinase 3 with Exquisite Kinome-Wide Selectivity and Their Functional EffectsFlorence F Wagner, Joshua A Bishop, Jennifer P Gale, et al.
Angewandte Chemie (International Ed. in English)|June 30, 2016
Discovery of a Highly Selective Glycogen Synthase Kinase-3 Inhibitor (PF-04802367) That Modulates Tau Phosphorylation in the Brain: Translation for PET NeuroimagingSteven H Liang, Jinshan Michael Chen, Marc D Normandin, et al.
Pageof 134